ProMIS Neurosciences, Inc.
PMN
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$13.27
FAIR PRICE
$19.20
MARGIN
$5.93
P/E Ratio
N/A
Div. Yield
N/A
ROE
12809.4%
Exceptional
Market Cap
$17M
Small-cap
COMING SOON
Get notified when PMN's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Neil K. Warma
COUNTRY
CA
HEADQUARTERS
Toronto
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate PMN's fair price
ProMIS Neurosciences, Inc.'s fair price of $19.20 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $13.27, PMN trades 44.7% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting PMN's risk profile.
RELATIVE · 30%
Comparing PMN's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for PMN, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate PMN's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for PMN.
Explore on BuliosFAQ
What is the fair price of PMN?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for ProMIS Neurosciences, Inc. is $19.20. At the current market price of $13.27, PMN trades 44.7% below its calculated fair value.
Is PMN overvalued or undervalued?+
ProMIS Neurosciences, Inc. is currently undervalued based on our valuation model. The stock trades at $13.27, which is 44.7% below the fair price of $19.20.
How often is PMN's fair price updated?+
We update fair price calculations for PMN daily after market close. The current fair price of $19.20 incorporates the latest market data and sector multiples.
What factors affect PMN's fair price calculation?+
PMN's fair price of $19.20 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 12809.4%.
Is PMN a good buy right now?+
At $13.27, PMN trades 44.7% below our fair value estimate of $19.20. The stock is currently undervalued. ROE stands at 12809.4% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does PMN pay dividends?+
PMN does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.